Özözen Ayas, ZeynepGündoğdu, Aslı Aksoy2022-05-112022-05-1120181300-7157https://doi.org/10.14744/epilepsi.2018.04796https://hdl.handle.net/20.500.11776/8926Bupropion inhibits reuptakes of dopamine and noradrenaline. Since it is also a nicotine receptor antagonist, it acts as a drug used for smoking cessation. Bupropion is commonly preferred because of no side effects on weight, sexual function, and the lack of sedative effect. Immediate and sustained-release bupropion forms may trigger seizure activity. In the present article, we report a case of a 30-year-old man presenting with generalized tonic clonic seizures induced by extended-release bupropion. We also emphasized that extended-release bupropion, which is commonly used for smoking cessation therapy, may cause seizure at early term and therapeutic dose.en10.14744/epilepsi.2018.04796info:eu-repo/semantics/openAccessExtended-release bupropionseizuresmoking cessation treatmentArticle243127129N/AWOS:000453839600007